False Positive in [99mTc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration

Teodoro Rudolphi Solero,Manuel Feriche Aragón,Tomader Amrani Raissouni,Alberto Delgado-García,Maria José Cañada-Rodríguez,Salomé Sanz Viedma
DOI: https://doi.org/10.1097/rlu.0000000000004981
IF: 10.6
2024-01-06
Clinical Nuclear Medicine
Abstract:[ 99m Tc]Tc-DPD (3,3-diphosphono-1,2-propanodicarboxylic acid) scintigraphy is an essential tool for diagnosing transthyretin amyloid cardiac amyloidosis. An 86-year-old woman suffering from heart failure with preserved ejection fraction underwent [ 99m Tc]Tc-DPD scintigraphy and a SPECT/CT for suspected transthyretin amyloid cardiac amyloidosis. The scan showed intracardiac and liver uptake. As the patient had taken intravenous iron on the morning of the scan, we decided to repeat the scan, but this time, it showed no uptake in the heart or the liver. Accordingly, we concluded the first result was a false positive due to drug interaction.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?